Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|269-2813|10|1170-1181

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.269-2813, Iss.10, 2015-11, pp. : 1170-1181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 10, 2015-11 ,pp. : 1170-1181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 504-514

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 734-746

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cognitive–Behavioral Therapy for Insomnia in Knee Osteoarthritis: A Randomized, Double‐Blind, Active Placebo–Controlled Clinical Trial

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 5, 2015-05 ,pp. : 1221-1233

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: sodium alginate oral suspension is non‐inferior to omeprazole in the treatment of patients with non‐erosive gastroesophageal disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 9, 2013-11 ,pp. : 1054-1064

John Wiley & Sons Inc

Access to resources Recommend Favorite